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Motivation. Natural language processing (NLP) techniques are used to extract information automatically from computer-
readable literature. In biology, the identiﬁcation of terms corresponding to biological substances (e.g., genes and proteins) is a
necessary step that precedes the application of other NLP systems that extract biological information (e.g., protein–protein in-
teractions, gene regulation events, and biochemical pathways). We have developed GPmarkup (for ‘‘gene/protein-full name mark
up’’), a software system that automatically identiﬁes gene/protein terms (i.e., symbols or full names) in MEDLINE abstracts. As a
part of marking up process, we also generated automatically a knowledge source of paired gene/protein symbols and full names (e.g.,
LARD for lymphocyte associated receptor of death) from MEDLINE. We found that many of the pairs in our knowledge source do
not appear in the current GenBank database. Therefore our methods may also be used for automatic lexicon generation.
Results. GPmarkup has 73% recall and 93% precision in identifying and marking up gene/protein terms in MEDLINE abstracts.
Availability: A random sample of gene/protein symbols and full names and a sample set of marked up abstracts can be viewed at
http://www.cpmc.columbia.edu/homepages/yuh9001/GPmarkup/. Contact. hy52@columbia.edu. Voice: 212-939-7028; fax: 212-666-
0140.
 2003 Elsevier Science (USA). All rights reserved.
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The current MEDLINE database includes over 12
million computer-readable records in the biomedical
domain and is expanding rapidly; it is a rich resource for
biological knowledge including protein–protein inter-
actions [1], gene regulation events [2], sub-cellular loca-
tions of proteins [3], and pathway discovery [4]. One way
to automatically extract information stored in MED-
LINE is to apply an information extraction system such
as a natural language processing (NLP) parser [5].* Corresponding author. Present address: Department of Computer
Science, Columbia University, Mudd 471, 116th, New York, NY
10029, USA. Fax: +212-666-0140.
E-mail addresses: Hongyu@cs.columbia.edu (H. Yu), vh@cs.
columbia.edu (V. Hatzivassiloglou), Andrey.Rzhesky@dmi.columbia.
edu (A. Rzhetsky), wilbur@ncbi.nlm.nih.gov (W. John Wilbur).
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is a necessary step towards an information extraction
system.
Genes and proteins are usually represented by sym-
bols and names in literature. The names usually are the
long forms of their symbols and describe the functions
of the genes or proteins. We hypothesize that authors
deﬁne gene/protein symbols in their articles when the
meanings are new in literature and the deﬁnitions can be
captured by a computer program. We also hypothesize
that if not all of the gene/protein symbols appearing in
an abstract are deﬁned, the deﬁnition may appear in
other abstracts. Therefore literature redundancy (e.g.,
the same genes or proteins are represented by diﬀerent
authors in diﬀerent articles) makes it plausible that we
may obtain automatically a relatively exhaustive gene/
protein symbol and full name table from all of MED-
LINE. In this study, we empirically tested all of the
above hypotheses.reserved.
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tation for automatic identiﬁcation of gene and protein
terms (i.e., symbols or full names) in MEDLINE ab-
stracts. As a part of the algorithm, we also present a
method for automatically generating a knowledge
source of paired gene/protein symbols (e.g., LARD) and
full names (e.g., lymphocyte associated receptor of death)
from MEDLINE. Our results show that a large number
of the pairs in our knowledge source do not appear in
LocusLink, a public database of gene/protein symbols
and corresponding full names [6,7].
A key step in our marking up methodology is to pair
gene/protein symbols to their names, so that we can use
biological function keywords (e.g., kinase) to diﬀeren-
tiate the symbols from other technical terms. For ex-
ample, by mapping abbreviation PKA to full name
protein kinase A, not to full form path of the kinematic
axis, we are able to identify PKA is a protein term since
keywords protein and kinase appear in the full form of
PKA.
We previously have developed a method that auto-
matically maps biomedical abbreviations to full forms.
In this study, we incorporated biological domain
knowledge into the method of mapping abbreviations to
full forms to enhance the mapping between gene/protein
symbols and full names. The biological domain knowl-
edge was obtained from manually reviewing published
guidelines of the nomenclature of genes and proteins.
We then developed a method to diﬀerentiate paired
gene/protein symbols and full names from other bio-
medical abbreviations and full forms.
To mark up gene/protein terms in MEDLINE ab-
stracts, we ﬁrst mark up gene/protein symbols and full
names when the full names are deﬁned. We then look up
the knowledge source we generated to mark up the re-
maining gene/protein terms. We generate the knowledge
source by extracting all pairs of gene/protein symbols
and full names from over eleven million MEDLINE
records (year 1966–2001).2. Background
A number of rule-based, linguistic, statistical, ma-
chine-learning, and hybrid approaches have been de-
veloped to mark up gene/protein terms automatically in
biological text. For example, Fukuda et al. (1998) ap-
plied morphological cues to identify protein terms (e.g.,
if a word contains uppercase letter(s) and special char-
acter(s), the word is a protein term). Gaizauskas et al.
(2000) identiﬁed protein terms through suﬃxes such as –
ase. Proux et al. (1998) identiﬁed non-English words as
gene terms. Linguistic approaches have mainly applied
part-of-speech tagging [8] or shallow parsing [9] to
identify noun phrases, from which gene/protein terms
were obtained. Hybrid approaches have combined lin-guistic with rule-based approaches for multi-word gene/
protein term recognition. For example [8], applied Brills
tagger [10] in combination with rules such as ‘‘connect
non-adjacent annotations if every word between them is
either noun, adjective, or a numeral’’ to identify multi-
word protein terms such as ras guanine nucleotide
exchange factor SOS. Tanabe and Wilbur [11] retrained
Brills tagger on the biomedical domain for gene/pro-
tein name-identiﬁcation. Statistical approaches have
clustered abstracts for keyword identiﬁcation [12].
Machine-learning approaches have applied na€ıve Bayes
[9], Hidden Markov Models [13], and decision trees [14],
to classify gene/protein terms. Other approaches include
lookup in knowledge sources such as GenBank and
SWISSPROT [15].
Our method of marking up gene/protein names is a
mixture of pattern-recognition and knowledge-based
approaches. We ﬁrst map gene/protein symbols to full
names when the full names are deﬁned. Those gene/
protein terms are then marked up. The rest of gene/
protein terms are identiﬁed from the gene/protein sym-
bol and full name knowledge source which we extracted
automatically from MEDLINE.
2.1. Systems that automatically map gene and protein
symbols to full names
A number of systems have been developed for auto-
matic mapping between abbreviations and full names
[16–23]. Those systems applied a variety of approaches
including linguistic, rule, and statistical methods and
reported precisions from 70–97%. Most of those systems
tend to be domain independent and therefore may not
perform ideally in a restricted domain such as biology.
For example, most of pattern-recognition approaches
[18,19] do not capture NKAIF (for sodium–potassium
ATPase inhibitory factor) since N and K represent so-
dium and potassium, respectively, and both letters do not
appear in the full name. In addition, most of the systems
do not diﬀerentiate gene/protein symbols from other
abbreviations and full names.
A system that was developed speciﬁcally for mapping
protein symbols to full names is PNAD-CSS (for ‘‘protein
full name abbreviation dictionary construction support
system’’) [24]. PNAD-CSS used morphological features
to recognize proper nouns as protein terms in biological
abstracts [8]. Knowing a phrase may contain a protein
symbol and full name, PNAD-CSS recognized paren-
theses and determined whether the parenthetical phrase
was an abbreviation of the outer phrase. Tomap a protein
symbol to its name, PNAD-CSS broke up words of the
preceding phrase, and determined whether the paren-
thetical abbreviation candidate maps to the initial letters
of the broken-up phrase. For example, consider the
phrase ‘‘megestrol acetate (megace).’’ PNAD-CSS parsed
‘‘megestrol acetate’’ as ‘‘meges trol ac etate,’’ which is then
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‘‘e’’ in ‘‘megace’’ match the initial letter(s) of ‘‘meges,’’
‘‘ac,’’ and ‘‘etate,’’ respectively.
We ﬁnd that PNAD-CSS has some limitations: it
applies morphological cues for protein term recognition
and the morphological cues may falsely identify as
protein symbols other substances (e.g., LSD-25 for ly-
sergic acid diethylamide), cell types (e.g., BHK-21 for
baby-hamster kidney-cell line), procedures (e.g., PCR for
polymerase chain reaction) as well as clinical syndromes
and diseases (e.g., CHF for congestive heart failure). This
is because many abbreviations that are not gene/protein
symbols consist of upper-case letters and numbers. The
PNAD-CSS pattern-matching rules also did not contain
special rules for protein names (for example, y repre-
sents tyrosine).
Previously, we have developed a system, AbbRE (for
‘‘abbreviation and full name recognition and extrac-
tion,’’ see [25]), that pairs biomedical abbreviations with
full names. AbbRE ﬁrst selected parenthetical expres-
sions and the phrases preceding the parenthesis as can-
didate abbreviations and full names. It then applied a set
of the pattern-matching rules to map abbreviations to
full names. The rules were obtained from the common
conventions authors use to create abbreviations. The
following rules were included: (1) the ﬁrst letter of an
abbreviation matches the ﬁrst letter of a meaningful word
of the full name; (2) the abbreviation matches the ﬁrst
letter of each word in the full name; (3) the abbreviation
letter matches consecutive letters of a word in the full
name and (4) the abbreviation letter matches a middle
letter of a word in the full name if the ﬁrst letter of the
word matches the abbreviation. AbbRE had 70% recall
and 95% precision in identifying paired abbreviations
and full names in biomedical articles.
Though AbbREs pattern-matching rules did not
contain special rules for protein names, AbbRE is ro-
bust and extensible. In this study (i.e., GPmarkup), we
manually examined the published guidelines of the no-
menclature of genes and proteins and added to AbbRE
special rules to enhance its mapping gene/protein sym-
bols to full names. In addition, we added in rules forTable 1
Guidelines that are useful for applying computational approaches to map a
1. A gene symbol should stand for a description of a phenotype, a gene
2. A gene symbol shall be short (between three to six characters) [26–32]
3. A gene symbol is an abbreviation of its full name [28].
4. If the symbol of a gene contains a character or property for which the
example, the single-letter abbreviation for amino acids used in aminoac
glucose, GSH for glutathione [31] and Bp for binding protein [32].
5. The initial character should always be a letter [29–33].
6. All Greek symbols should be changed to letters in the Latin alphabet
7. Amino acids have their special symbols [34].
8. The protein symbol is the same as the gene symbol [33].
9. The creator of a gene full name shall follow the guidelines and get consu
10. Gene full names should be included in the abstracts of any relevant pdiﬀerentiating gene/protein terms from other biomedical
terms.3. Methods and results
Our method section consists of six sub-sections: (1)
Mapping gene/protein symbols to full names as well as
abbreviations to full names. (2) Generating a knowledge
source of paired abbreviations and full names from
MEDLINE abstracts. (3) Filtering out other abbrevia-
tion-full name pairs to produce a knowledge source of
paired gene/protein symbols and full names. (4) Mark-
ing up gene/protein terms in MEDLINE abstracts. (5)
Evaluating GPmarkup. (6) Measuring the percentage of
deﬁned gene/protein symbols in MEDLINE abstracts.
3.1. Mapping gene/protein symbols to full names
To understand how gene/protein abbreviation-full
name pairs are created in the ﬁrst place, we examined a
number of published guidelines for the nomenclature of
genes and proteins. We found those guidelines are al-
most always species-speciﬁc (that is applicable only to
genes and proteins from, say, yeast, and not rat). Spe-
cies-speciﬁc may be caused by the fact that the com-
mittees for the nomenclature are formed by experts
specializing on a particular model organism. Table 1
lists guidelines that were useful for mapping abbrevia-
tions to full forms.
Analysis of the published guidelines allowed us to
identify some special abbreviations that are used for
gene/protein nomenclature (see Table 2) and to develop
the pattern-matching rules that map gene/protein sym-
bols to names.
3.1.1. Special abbreviations
See Table 2.
3.1.2. Pattern-matching rules
GPmarkup applies a set of pattern-matching rules to
map gene/protein symbols to full names when the fullgene or a protein symbol to its full name
product or a gene function [26].
.
re is a recognized abbreviation, the abbreviation should be used; for
yl residues or approved biochemical Abbreviations such as GLC for
[31].
ltation from curator of the guideline before journal publication [26].
apers [26].
Table 2
Special abbreviations that are used in gene/protein nomenclature
Type
Amino acids We use all one letter codes where these diﬀer from the ﬁrst letter of the amino acid. For example, tyrosine—Y (SYK for
spleen tyrosine kinase)
Two chemical
symbols used
Sodium–Na, potassium–K (NKAIF for sodium–potassium ATPase inhibitory factor)
Three other
symbols used
Inhibitor—N or NH, box—X (CDKN1A for cyclin-dependent kinase inhibitor 1A (p21, Cip1), CDX1 for caudal type homeo
box transcription factor 1)
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matching rules adapted AbbREs (as described in
Section 2.1) with the following modiﬁcations and ex-
tensions:
Rule 1: Any number and special character is ignored
for mapping gene/protein symbols to full names.
We added in a rule to map letters only. We ignored
numbers and special characters (e.g., ‘‘+’’) due to the
following two reasons:
(1) Many numbers and special characters in a gene or a
protein symbol do not appear in their full names.
For example, CYP2C19 for cytochrome P450, sub-
family IIC (mephenytoin 4-hydroxylase), where
‘‘19’’ is not represented and ‘‘2’’ is represented by
‘‘II.’’
(2) Many numbers in gene or protein symbols order dif-
ferently in their full names (e.g., ALOX12 for ara-
chidonate 12-lipoxygenase, where ‘‘12’’ in the
symbol ‘‘ALOX12’’ is after ‘‘LOX’’ that represents
lipoxygenase, but before ‘‘lipoxygenase’’ in the full
name ‘‘arachidonate 12-lipoxygenase’’).
Rule 2: Special abbreviation substitutions
We substitute some nouns with their special abbre-
viations when we apply the pattern-matching rules. For
example, instead of mapping DYRK1A to dual-speciﬁc-
ity tyrosine phosphorylation regulated kinase 1A, we at-
tempt to map DYRK1A to dual-speciﬁcity Y
phosphorylation regulated kinase 1A, where tyrosine has
been replaced by Y. After the mapping, we recover the
original terms.
In reality, not all the authors use the special abbre-
viations (listed in Table 2) for their nomenclature. An
example is PTK2B for protein tyrosine kinase 2 b, where
tyrosine is represented by its common abbreviation T
instead of Y. Therefore, our algorithm considers both
types of mapping (with and without substitution of a
special noun with a shorthand) and selects the best
matching version.
For example, we attempt to map PTK2B to both
protein tyrosine kinase 2 b and protein Y kinase 2 b; we
map DYRK1A to both dual-speciﬁcity tyrosine phos-
phorylation regulated kinase 1A and dual-speciﬁcity Y
phosphorylation regulated kinase 1A.
When a full name has more than one word that has
many abbreviations, we include all of the combinations
for substitution. For example, in case of NK AIF forsodium–potassium ATPase inhibitory factor, we at-
tempted to map NKAIF to sodium–potassium ATPase
inhibitory factor, Na–potassium ATPase inhibitory factor,
sodium–K ATPase inhibitory factor, and Na–K ATPase
inhibitory factor. We found that Na–K ATPase inhibitory
factor was mapped and we recovered the original full
name.
3.1.3. Parenthetic pattern
Prior to pattern-matching rules, GPmarkup selects
candidate abbreviations and full names. For this task,
GPmarkup recognizes special patterns such as ‘‘<ab-
breviation>(<full name>)’’ or ‘‘<full name>(<abbrevi-
ation>)’’. Recall AbbRE also recognized these patterns.
However, AbbRE can not recognize gene/protein terms
that incorporate nested parentheses. For example, Ab-
bRE fails to map acyl-coenzyme A (acyl-CoA) dehydro-
genases to ACD from the following string extracted
from [35] the expression of various acyl-coenzyme A
(acyl-CoA) dehydrogenases (ACD) since it parses into
the following two components:
the expression of various acyl-coenzyme A (acyl-CoA) and dehy-
drogenases (ACD)
To correct for this shortcoming, we introduced into
the newer algorithm (GPmarkup) an additional rule to
recognize gene/protein full names that incorporate pa-
rentheses. It then parses the above string into the fol-
lowing two components:
the expression of various acyl-coenzyme A (acyl-CoA) and the ex-
pression of various acyl-coenzyme A (acyl-CoA) dehydrogenases
(ACD)
where the phrases preceding and within the parentheses
in each component incorporate candidate abbreviations
and full names, to which GPmarkup further applies its
pattern-matching rules to map abbreviations to full
names.3.2. Generating a knowledge source of paired abbrevia-
tions/full names from MEDLINE abstracts
We applied GPmarkup to 11 million MEDLINE re-
cords (1966–2001), which contain the same number of
titles and over six million abstracts (note that not all
MEDLINE records contain abstracts). We obtained a
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of abbreviations and full names. The most frequently
deﬁned abbreviations were PCR (polymerase chain re-
action, which appeared in 7988 abstracts) and NO (nitric
oxide, which appeared in 7855 abstracts).
3.3. Filtering out other abbreviation-full name pairs to
produce a knowledge source of paired gene/protein
symbols and full names
The algorithm outlined above also identiﬁes a large
number of general abbreviations that are not gene/pro-
tein symbols and full names. We therefore developed a
rule-based approach to partition our knowledge source
of abbreviation-full name pairs into gene/protein sym-
bol-full name pairs and other abbreviation-full name
pairs.
Our rule-based approach combines morphological
cues, functional keywords, and position-functional
keywords to ﬁlter out non-gene/protein terms. The ap-
proach is described as follows:
If an abbreviation contains a number, the abbrevia-
tion and full name is a gene/protein symbol-full name
pair only if the full name contains one or more of the
following keywords (denoted as set K1): protein(s),
gene(s), peptide(s), molecule(s), enzyme(s), ligand(s),
compound(s), receptor(s), channel(s), transcriptor(s),
regulator(s), inhibitor(s), antibody, antibodies, globu-
lin(s), factor(s), motif, domain(s), compound(s), seg-
ment(s), subunit(s), locus, loci, cassette(s), chain,
complex(es), homeobox(es), box(es), member(s), dele-
tion, axon, family, families, chromosome(s), sequence,
a, b, c, interleukin and any words except for disease
that ends in –ase.
If an abbreviation does not contain a number, the ab-
breviation and full name is gene/protein symbol-full
name pair only if the last word of the full name is a
keyword in set K1.
We obtained functional keywords by manually ex-
amining all of the entries in LocusLink. Note that some
keywords (e.g., ‘‘gene’’) in set K1 can appear as both the
last word or the middle word of a gene/protein term
(e.g., Btg4 for B-cell translocation gene 4 and AFG3L1
for AFG3 (ATPase family gene 3, yeast)-like 1). On the
other hand, some keywords (e.g., ‘‘chromosome’’) do
not appear as the last word of, but only within a gene/
protein term (e.g., C10ORF2 for chromosome 10 open
reading frame 2).
We applied the rules to abbreviations and full
names and generated a knowledge source of 86,767
unique pairs of gene/protein symbols and full names.
The most frequently deﬁned gene/protein symbols in-
cluded egf (for epidermal growth factor, appears in
2023 abstracts), il (for interleukin, appears in 2183
abstracts), and ldl (for low density lipoprotein, appears
in 2673 abstracts).3.4. Marking up gene/protein terms in MEDLINE
abstracts
We further developed and implemented an algorithm
to mark up gene/protein terms in MEDLINE abstracts.
GPmarkup ﬁrst maps abbreviations to full names and
then performs the markup for any abbreviation with an
identiﬁed full name (details in Sections 3.2 and 3.3). For
the remaining terms in abstracts, we looked up the
knowledge sources of paired abbreviations and full
names and paired gene/protein symbols and names. As
an eﬀort to achieve a higher precision, we only looked
up multi-word gene/protein terms, since a single word
term could be ambiguous (for example, aap denotes
antiarrhythmic peptide or automatic action potential, the
former is a protein name, and the latter is not).
When a string can be mapped to several terms stored
in our knowledge sources, GPmarkup favors longer
term mapping and markup. It does not mark up a term
which is used as a modiﬁer of entity other than genes
and proteins. For example, GPmarkup does not markup
the protein term amyloid b protein in a string of cerebral
amyloid b protein angiopathy, because the protein name
is used as a modiﬁer for the disease term angiopath.
GPmarkup applies direct matching (i.e., the string in
text exactly appears in our knowledge sources) except
that GPmarkup includes a word that immediately fol-
lows a gene or a protein symbol or full name if the word
either consists of a number or is a functional keyword
including ‘‘gene,’’ ‘‘protein,’’ ‘‘homologue,’’ and ‘‘re-
ceptor.’’ For example, knowing a b and il12 p40 as gene
or protein symbols, GPmarkup also identiﬁes a b40 and
il12 p40 homologue.
3.5. GPmarkup evaluation
We performed evaluation in the following three steps:
(1) mapping abbreviations to full names, (2) ﬁltering out
other terms to produce a knowledge source of paired
gene/protein symbols and names, and (3) marking up
gene/protein terms in MEDLINE abstracts. We there-
fore evaluate GPmarkup phase by phase. We also
compared the knowledge source of paired gene/protein
symbols and full names with the ones in LocusLink. We
evaluated by recall (i.e., number of correct answers
identiﬁed by our system divided the total number of
correct answers) and precision (i.e., number of correct
answers divided by the total number of answers speciﬁed
by our system). We estimated conﬁdence intervals for
these measures based on the binomial distribution.
3.5.1. Mapping abbreviations to full names
We randomly (by time of publication) selected 30
MEDLINE abstracts and asked three biomedical experts
(all with PhD orMD) to map abbreviations to full names
when the full names are deﬁned within the abstracts. The
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perts. GPmarkup correctly mapped 56 abbreviations and
full names out of a total of 59 pairs that were determined
by experts. GPmarkup wrongly identiﬁed one pair that
was not an abbreviation and full name. GPmarkups re-
call and precision in identifying and extracting abbrevi-
ations and full nameswere, with 95% conﬁdence intervals,
0.95 (0.86–0.99) and 0.98 (0.91–1.00), respectively.
3.5.2. Filtering out other terms
We then evaluated our rule-based approach for parti-
tioning the knowledge source of abbreviation-full name
pairs into gene/protein symbol-full name pairs and other
abbreviation-full name pairs. We randomly selected 1000
pairs of gene/protein symbols and full names and 1000
pairs of other abbreviations and full names partitioned by
GPmarkup and evaluated recall and precision of the
partitioning. We asked experts (see 3.5.1) for help in de-
ﬁning a gold standard. Table 3 lists the results of the
evaluation. Note that GPmarkup included some incom-
plete-matches of abbreviations and full names (e.g., {il-6,
interleukin}). Since the ratio of gene/protein symbol-
names to other abbreviation-full name pairs was 1:5.6
(86,767/[574,327–86,767]); the numbers were described in
Sections 3.2 and 3.3), GPmarkup had an accuracy of
0.95 0.02, with 95% conﬁdence. The ﬁgure 0.95 comes
from the ratio ð982þ 949  5:6Þ=ð1000 þ 1000  5:6Þ
which is based on the numbers inTable 3 and their relative
frequencies as just computed.
3.5.3. Marking up gene/protein terms in MEDLINE
abstracts
We then evaluated GPmarkup in marking up gene/
protein terms in MEDLINE abstracts. We randomly (byTable 3
Evaluation results of GPmarkup in ﬁltering the knowledge source of paired
gene/protein symbols and full names
Evaluation cases Expert judgments
Number of gene/protein
symbol-full name pairs
1000 pairs of gene/protein symbols and
full names as identiﬁed by GPmarkup
982
1000 pairs of other abbreviations and
full names as identiﬁed by GPmarkup
1 (i.e., A-Igg for
Anti-human Igg)
Table 4
Evaluation results of GPmarkup
Type of category
Complete-matching (e.g., <phr sem¼ ‘‘gp’’ t¼ ‘‘signaling lymphocyte activ
Partial-matchinga (e.g., <phr sem¼ ‘‘gp’’>interleukin 1</phr> receptor ii)
Missing (e.g., 2b4)
False-matchingb (e.g., <phr sem¼ ‘‘gp’’>acupuncture points and channels<
aThe correct full name is ‘‘interleukin 1 receptor ii’’.
b False-matching includes those non-gene and non-protein terms that aretime of publication) selected 50 MEDLINE abstracts,
which consists of a total of 539 sentences (including the
title). Some selected abstracts did not cover biological
domain and therefore did not have gene/protein terms at
all. Therefore, we did not select only biological abstracts
for evaluation because we judge a false markup is as bad
as a missing markup. We therefore judged that a random
selection of abstracts best reﬂects our systems recall and
precision.
Table 4 lists the evaluation results of the 50 abstracts.
GPmarkup applies XML format for term mark up. For
example, the tag ‘‘phr’’(for ‘‘phrase’’) has attributes in-
cluding ‘‘sem’’ (for ‘‘semantic category’’) that has value
‘‘gp’’ (for ‘‘gene and protein terms’’) and ‘‘t’’ (for ‘‘tar-
get’’) that represents gene/protein full names. We count
any appearance of gene/protein terms. For example, if
protein ‘‘amyloid b protein’’ appears three times in the
abstract, we count three instead of one for this case. We
posted a sample set ofmarked up abstracts at http://www.
cpmc.columbia.edu/homepages/yuh9001/GPmarkup/).
From Table 4, if we count a partial-matching as a
match, the recall and the precision of GPmarkup were,
with 95% conﬁdence, 0.73 0.05 ð222þ 15Þ=ð222 þ
15þ 88Þ and 0.93 0.03 ð222þ 15Þ=ð222þ 15þ 17Þ,
respectively. We found all partial matches represent valid
proteins. However, if we do not include a partial-match-
ing as a match, the recall and precision of GPmarkup
were, with 95% conﬁdence, 0.68 0.05 222=ð222þ 15 þ
88Þ and 0.87 0.04 ð222=ð222þ 15þ 17Þ, respectively.
3.5.4. Comparing gene/protein symbols and full names
extracted from MEDLINE with LocusLink
We downloaded the knowledge source of paired gene/
protein symbols and full names from LocusLink [36].abbreviations and full names to produce a knowledge source of paired
Number of other
abbreviation-full name pairs
Number of non abbreviation-full
name pairs
9 (e.g, srg for spent
restaurant grease)
9 (e.g., gene for genes)
949 50 (e.g., ph2 for phages)
GPmarkup identiﬁed
ation molecule’’>slam</phr> 222
15
88
/phr>) 17
identiﬁed by GPmarkup.
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Biotechnology Information. It presents information on
oﬃcial nomenclature of genes and lists a total of 115,890
manually annotated paired gene symbols and full
names, though we found that only 65,987 entries have
both gene/protein symbols and full names.
We randomly selected 100 entries that incorporate
both symbols and full names from the LocusLink and
manually identify their existence in our knowledge
source of paired gene/protein symbols and full names.
We also randomly selected 100 unique gene/protein
symbol and full name pairs from our knowledge source
and manually identiﬁed their existence in LocusLink.
We found that 62 out of 100 selected pairs in our
knowledge source did not appear in LocusLink. Exam-
ples included {ACY1-ACP, acyl-acyl carrier protein},
{GCDFP, gross cyst disease ﬂuid protein}, {CCK-OP,
cholecystokinin octopeptide} and {l-PK, l pyruvate ki-
nase} though some of the missing pairs represent protein
products instead of direct genes. For example, {l-PK, l
pyruvate kinase} is a spliced product of its gene {PKLR,
pyruvate kinase},1 which appears in LocusLink and
there is no gene for {CCK-OP, cholecystokinin octo-
peptide}.2 Eight pairs partially matched to LocusLink.
For example, PPI, peptide prolyl cis trans isomerase
appears in our knowledge source. In LocusLink, we
found {PPIa, peptidylprolyl isomerase a (cyclophilin
a)}.’’
On the other hand, we found that only 40 LocusLink
entries could be found in our knowledge source (16 of
them have variations). We judged that four of those 60
failed entries are not gene/protein symbols and full
names (e.g., {shs, sutherland-haan x-linked mental re-
tardation syndrome}). To ﬁnd whether the remaining 56
entries exist in MEDLINE, we searched 12 million
MEDLINE records (1966–2002). We applied direct
matching (case insensitive) and manually analyzed ab-
stracts that contained either the symbol or the full name
of those 56 failed entries. We failed to ﬁnd the existence
of 50 of them in MEDLINE, either symbols or full
names. Examples include {2700088m22rik, riken cdna
2700088m22 gene} and {atp5bl1, atp synthase, h+
transporting, mitochondrial f1 complex, b polypeptide-
like 1}. Of the rest of six entries, we could ﬁnd symbols
in MEDLINE, but failed to ﬁnd full names. Examples
include {aspa, aspartoacylase (aminoacylase 2, canavan
disease)} and {assp6, argininosuccinate synthetase
pseudogene 6}, for the former we found the full name
with variations, for the latter we found that the full
name did not exist in the MEDLINE record where the
symbol appeared.1 GenBank Accession No. U47654.
2 For details see http://arbl.cvmbs.colostate.edu/hbooks/pathphys/
endocrine/gi/cck.html).3.6. The percentage of undeﬁned gene/protein symbols and
full names
If all the gene/protein symbols and full names were
deﬁned in MEDLINE abstracts, then GPmarkup would
also serve the purpose for disambiguation by assigning
full names to symbols. However, not all the gene/protein
symbols are deﬁned in the abstracts.
We measured the percentage of deﬁned gene/protein
symbols in MEDLINE abstracts. We randomly selected
100 abstracts (according to the timeof publication) froma
total of 782,560 MEDLINE abstracts (1966–2001) that
were retrieved by the keyword ‘‘protein.’’ Those abstracts
contain 1069 sentences (including titles). We measured
the percentage of undeﬁned gene/protein symbols. We
counted unique appearance of gene/protein symbols
within abstracts. Based on the authors judgment, the
numbers of deﬁned and undeﬁned gene/protein symbols
were 92 and 27, respectively. The percentage of deﬁned
gene/protein symbols and full names was, with 95% con-
ﬁdence, 0.77 0.08.4. Discussion
Many public databases such as GenBank have gene/
protein synonym knowledge sources. However, the da-
tabases are largely maintained manually and therefore
are not always up to date. GPmarkup can generate
automatically a knowledge source of paired gene/protein
symbols and full names from MEDLINE abstracts. The
automated fashion may reduce manual eﬀorts. In addi-
tion, GPmarkup may capture the most up-to-date gene/
protein symbols and full names if the full names are
deﬁned in abstracts and follow the guidelines of no-
menclature of genes and proteins.
We also found that a majority of gene/protein symbols
and full names extracted in our knowledge source did not
appear in LocusLink. Recall LocusLink consists of a
large number of mainly manually annotated paired gene/
protein symbols and full names. In addition, we found a
majority of pairs in LocusLink did not appear in our
knowledge source either; most of those pairs did not even
appear in MEDLINE by keyword search. The results
suggest that there is a gap between LocusLink knowledge
source and the actual text. This diﬀerence may make it
diﬃcult to apply LocusLink directly for looking up terms
in MEDLINE. On the other hand, since our knowledge
source of paired gene/protein symbols and names were
directly extracted from MEDLINE, they may be more
useful as a knowledge-based markup.
One limitation of GPmarkup is that not all the gene/
protein symbols and full names are deﬁned in the ab-
stracts and therefore GPmarkup may not capture some
gene/protein symbols and full names.However, two other
factors alleviate this problem: authors are encouraged to
H. Yu et al. / Journal of Biomedical Informatics 35 (2002) 322–330 329deﬁne gene/protein full names in the abstracts of any
relevant papers [26], and the literature is redundant.
Therefore, applying GPmarkup to all of MEDLINE ab-
stracts is likely to capture a majority of gene/protein
symbols and full names that appear in the text.
GPmarkup may also miss gene/protein symbols and
full names when authors do not follow the guidelines for
naming genes and proteins. To capture these gene/protein
symbols and full names, wemay integrate intoGPmarkup
statistical approaches such as Hisamitsu and Niwas ap-
proach [18,20] of selecting phrases associated with pa-
rentheses that were statistically signiﬁcant. In addition,
GPmarkup may also miss abbreviations and full names
that are introduced through syntactic patterns (e.g., ap-
positions). In the near future we plan to utilize the ap-
proaches of [37] that enumerated syntactic patterns for
abbreviation detection.
Other limitations include the ambiguity in usage of
gene/protein terms. For example, we do not diﬀerentiate
a gene term from a protein one. We do not diﬀerentiate
a general gene/protein term (e.g., growth factors) from a
speciﬁc one (e.g., protein kinase A). We also do not
identify to which organism, tissue, cell type, and sub-
location a gene/protein term refers. We propose to in-
tegrate the approach of [38] for disambiguating gene/
protein terms. We also hope to develop statistical NLP
approaches for further disambiguation.
Our study shows that many gene/protein symbols
(77%) are deﬁned within the abstracts, GPmarkup can
map a majority of gene/protein symbols to full names.
GPmarkup does not mark up undeﬁned gene/protein
symbols if the symbols have several full names in the
knowledge source of abbreviation-full name pairs. For
example, aap denotes antiarrhythmic peptide, alkyl ac-
ceptor protein, alzheimer amyloid precursor protein, am-
inoantipyrine, and automatic action potential in our
knowledge source and GPmarkup thus does not mark up
‘‘aap’’ as a gene/protein term when it is not deﬁned in the
abstract. We therefore sacriﬁce GPmarkups recall for
high precision. In the future, we will integrate a disam-
biguation method that assigns the full names from our
knowledge source to the ambiguous symbols. Once a
symbol is assigned to its full name, we can apply our rule-
based approach (see Section 3.3) determining whether the
symbol is a gene/protein term.
Note that we recognized a gene/protein term if the
term actually represents a gene/protein in the abstract.
We described earlier that we did not mark up ‘‘cerebral
amyloid b protein angiopathy’’ as a protein name even
though ‘‘cerebral amyloid b protein’’ by itself is a protein
name. Other researchers may do diﬀerently [11].
5. Conclusion
This study shows that GPmarkup is eﬃcient (73%
recall and 93% precision) in marking up gene/proteinterms in MEDLINE abstracts. Our results may provide
a useful supplement to manually curated resources such
as LocusLink (GenBank). A method to more accurately
identify the full names of undeﬁned abbreviations would
increase the recall of GPmarkup and enhance its use-
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